TScan Therapeutics (TCRX) Insider Trading & Ownership $2.40 -0.06 (-2.44%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TScan Therapeutics (NASDAQ:TCRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.76%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$86,659.98Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$951,885.08 Get TCRX Insider Trade Alerts Want to know when executives and insiders are buying or selling TScan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TCRX Insider Buying and Selling by Quarter TScan Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/15/2024Lynx1 Capital Management LpMajor ShareholderBuy947$4.34$4,109.98 9/23/2024Barbara KlenckeDirectorBuy5,000$5.29$26,450.00 8/26/2024Barbara KlenckeDirectorBuy5,000$5.53$27,650.00 8/23/2024Barbara KlenckeDirectorBuy5,000$5.69$28,450.00 8/23/2024Zoran ZdraveskiInsiderSell164,686$5.78$951,885.08 (Data available from 1/1/2013 forward) TCRX Insider Trading Activity - Frequently Asked Questions Who is on TScan Therapeutics's Insider Roster? The list of insiders at TScan Therapeutics includes Barbara Klencke, Brian M Silver, David P Southwell, Lynx1 Capital Management Lp, Timothy J Barberich, and Zoran Zdraveski. Learn more on insiders at TCRX. What percentage of TScan Therapeutics stock is owned by insiders? 2.76% of TScan Therapeutics stock is owned by insiders. Learn more on TCRX's insider holdings. Which TScan Therapeutics insiders have been buying company stock? The following insiders have purchased TCRX shares in the last 24 months: Barbara Klencke ($107,950.00), Lynx1 Capital Management Lp ($4,109.98), and Timothy J Barberich ($240,603.10). How much insider buying is happening at TScan Therapeutics? Insiders have purchased a total of 87,657 TCRX shares in the last 24 months for a total of $352,663.08 bought. Which TScan Therapeutics insiders have been selling company stock? The following insiders have sold TCRX shares in the last 24 months: Lynx1 Capital Management Lp ($64,008.00), and Zoran Zdraveski ($951,885.08). How much insider selling is happening at TScan Therapeutics? Insiders have sold a total of 190,086 TScan Therapeutics shares in the last 24 months for a total of $1,015,893.08 sold. TScan Therapeutics Key ExecutivesDr. Gavin MacBeath Ph.D. (Age 54)CEO & Director Compensation: $650.17kDr. Stephen J. Elledge Ph.D.Co-Founder & Chairman of Scientific Advisory BoardMr. Tomasz Kula Ph.D.Co-Founder & Member of Advisory BoardMr. Jason A. Amello (Age 56)Chief Financial Officer Mr. Leiden Dworak M.B.A.Principal Accounting Officer & TreasurerDr. Justin McCue Ph.D.Chief Technology OfficerMs. Ann HargravesSenior Vice President of Human ResourcesDr. Shrikanta Chattopadhyay M.D.Senior VP & Head of Translational Medicine More Insider Trading Tools from MarketBeat Related Companies KURA Insider Ownership TECX Insider Ownership CRGX Insider Ownership HUMA Insider Ownership ANNX Insider Ownership KROS Insider Ownership MREO Insider Ownership RAPP Insider Ownership DNA Insider Ownership TRDA Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:TCRX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TScan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
